Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM
Clinical trial NCT03452579 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03452579
- Sponsor
- David Peereboom
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-21
- Primary completion
- 2020-12-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.